Javitt Jonathan C
SEC CIK 1303782 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | Dir, 10% | 84.6K | $6.00M | $400.0K | 6 | 2022-06-01 | 2024-12-17 |
Most active insiders at NRXP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Javitt Jonathan C made no open-market trades at NRXP in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | 2024-12-17 | NRXP | NRX Pharmaceuticals, Inc. | Javitt Jonathan C | COB, Chief Scientist, Dir, 10% | P - Purchase | $1.17 | +40.0K | 84.6K | +90% | +$46.8K | |
| 2023-08-24 | 2023-08-23 | NRXP | NRX Pharmaceuticals, Inc. | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.33 | +100.0K | 446.3K | +29% | +$33.0K | |
| 2023-08-23 | 2023-08-22 | NRXP | NRX Pharmaceuticals, Inc. | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.32 | +200.0K | 346.3K | +137% | +$64.0K | |
| I | 2022-12-09 | 2022-12-07 | NRXP | NRX Pharmaceuticals, Inc. | Javitt Jonathan C | Dir, 10% | S - Sale | $1.00 | -400.0K | 12.90M | -3% | -$400.0K |
| 2022-06-02 | 2022-06-01 | NRXP | NRX Pharmaceuticals, Inc. | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $58.00 | +100.0K | 146.3K | +216% | +$5.80M | |
| A | 2022-06-02 | 2022-06-01 | NRXP | NRX Pharmaceuticals, Inc. | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.58 | +100.0K | 146.3K | +216% | +$58.0K |
Purchase Sale Sale after option exercise All abbreviations